Impact of Preemptive Therapy for Cytomegalovirus on Hospitalizations and Cost after Hematopoietic Stem Cell Transplantation

類似資料

• Impact of Preemptive Therapy for Cytomegalovirus on Toxicities after Allogeneic Hematopoietic Cell Transplantation in Clinical Practice: A Retrospective Single-Center Cohort Study
  著者:: Zavras, Phaedon, 等
  出版事項: (2020)
• 1104. Risk Factors and Outcomes of Refractory and/or Resistant Cytomegalovirus (CMV) Infection after Allogeneic Hematopoietic Stem Cell Transplantation
  著者:: Karantoni, Eleni, 等
  出版事項: (2020)
• 1742. Kinetics of CMV Viremia with Letermovir Prophylaxis in the First 100 Days post Hematopoietic Cell Transplantation (HCT): A Single-center Experience
  著者:: Zavras, Phaedon D, 等
  出版事項: (2019)
• 91. Differential Impact of Cytomegalovirus (CMV) Donor (D) Serostatus on Rates and Kinetics of CMV Viremia among CMV Seropositive Recipients (R+) of Ex vivo T-cell Depleted (TCD) and Unmodified (CONV) Hematopoietic Cell Transplants (HCT)
  著者:: Stern, Anat, 等
  出版事項: (2019)
• Cytomegalovirus Viremia and Death After Hematopoietic Cell Transplantation: More Complex Than “To Have and Have Not”?
  著者:: Perales, Miguel-Angel, 等
  出版事項: (2020)